Metabolic dysfunction-associated fatty liver disease (MAFLD), a globally prevalent condition, can lead to serious complications, such as liver cirrhosis, hepatocellular carcinoma, and an increased risk of hepatic failure and mortality. MAFLD progression is influenced by various factors, including lipid overload, mitochondrial dysfunction, reactive oxygen species (ROS) production, and inflammation. Corylin, a flavonoid extracted from Psoralea corylifolia L., possesses multiple beneficial properties, including anti-inflammatory, antiproliferative, antiobesity, and antioxidant effects, and can alleviate hyperglycemia, hyperlipidemia, and insulin resistance. However, the beneficial potential of corylin for MAFLD has not been explored. Herein, we investigated the effects of corylin on MAFLD.
Results:
Corylin reduced plasma hyperglycemia, ROS levels, lipid accumulation, inflammation, and fibrosis in livers of high-fat diet (HFD)-fed mice; additionally, it improved insulin resistance and enhanced glycogen synthesis. In palmitic acid (PA)-treated HepG2 cells, corylin decreased excessive lipogenesis, ROS production, and mitochondrial dysfunction while promoting glucose uptake, glycogen synthesis, and mitochondrial activation. Furthermore, corylin reduced inflammation in PA-treated RAW264.7 macrophages and decreased fibrotic protein expression in TGF-β-treated LX-2 hepatic stellate cells (HSCs). The regulatory effects of corylin on PA-treated HepG2 cells and RAW264.7 macrophages were mediated through adenosine 5′-monophosphate-activated protein kinase regulation; however, similar effects were not observed in transforming growth factor beta-stimulated LX-2 HSCs.
Innovation:
These findings suggest that corylin has anti-ROS, anti-inflammatory, antilipogenic, and antifibrotic properties.
Conclusions:
Consequently, corylin is a promising beneficial candidate for the treatment of MAFLD. Antioxid. Redox Signal. 44, 910–927.
ChangZY, LiuHM, LeuYL, et al.Modulation of gut microbiota combined with upregulation of intestinal tight junction explains anti-inflammatory effect of corylin on colitis-associated cancer in mice. Int J Mol Sci, 2022; 23(5):2667; doi: 10.3390/ijms23052667
3.
CheZ, ZhouZ, LiSQ, et al.ROS/RNS as molecular signatures of chronic liver diseases. Trends Mol Med, 2023; 29(11):951–967; doi: 10.1016/j.molmed.2023.08.001
4.
ChenCC, ChenCY, UengSH, et al.Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair. Cell Death Dis, 2018a;9(5):543; doi: 10.1038/s41419-018-0575-0
5.
ChenCC, ChenCY, YehCT, et al.Corylin attenuates CCl(4)-induced liver fibrosis in mice by regulating the GAS6/AXL signaling pathway in hepatic stellate cells. Int J Mol Sci, 2023; 24(23):16936; doi: 10.3390/ijms242316936
6.
ChenCC, KuoCH, LeuYL, et al.Corylin reduces obesity and insulin resistance and promotes adipose tissue browning through SIRT-1 and beta3-AR activation. Pharmacol Res, 2021a;164:105291; doi: 10.1016/j.phrs.2020.105291
7.
ChenCC, LiHY, LeuYL, et al.Corylin inhibits vascular cell inflammation, proliferation and migration and reduces atherosclerosis in ApoE-deficient mice. Antioxidants (Basel), 2020; 9(4):275; doi: 10.3390/antiox9040275
8.
ChenCY, ChenCC, ShiehTM, et al.Corylin suppresses hepatocellular carcinoma progression via the inhibition of epithelial-mesenchymal transition, mediated by long noncoding RNA GAS5. Int J Mol Sci, 2018b;19(2):380; doi: 10.3390/ijms19020380
9.
ChenIC, WangSC, ChenYT, et al.Corylin ameliorates LPS-induced acute lung injury via suppressing the MAPKs and IL-6/STAT3 signaling pathways. Pharmaceuticals (Basel), 2021b;14(10):1046; doi: 10.3390/ph14101046
10.
ChenX, WangH, WuC, et al.Endothelial H(2)S-AMPK dysfunction upregulates the angiocrine factor PAI-1 and contributes to lung fibrosis. Redox Biol, 2024; 70:103038; doi: 10.1016/j.redox.2024.103038
11.
ClareK, DillonJF, BrennanPN. Reactive oxygen species and oxidative stress in the pathogenesis of MAFLD. J Clin Transl Hepatol, 2022; 10(5):939–946; doi: 10.14218/JCTH.2022.00067
12.
DuD, LiuC, QinM, et al.Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B, 2022; 12(2):558–580; doi: 10.1016/j.apsb.2021.09.019
FriedmanSL. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 2008; 88(1):125–172; doi: 10.1152/physrev.00013.2007
15.
GuoY, ZhangY, HongK, et al.AMPK inhibition blocks ROS-NFkappaB signaling and attenuates endotoxemia-induced liver injury. PLoS One, 2014; 9(1):e86881; doi: 10.1371/journal.pone.0086881
16.
HaoY, SongS, LiT, et al.Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells. Int J Biol Sci, 2024; 20(7):2422–2439; doi: 10.7150/ijbs.92749
17.
HeL, HuangC, WangH, et al.Galanin ameliorates liver inflammation and fibrosis in mice by activating AMPK/ACC signaling and modifying macrophage inflammatory phenotype. Front Immunol, 2023; 14:1161676; doi: 10.3389/fimmu.2023.1161676
HuangMY, TuCE, WangSC, et al.Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia. BMC Complement Altern Med, 2018; 18(1):221; doi: 10.1186/s12906-018-2287-5
20.
HuangR, GuoF, LiY, et al.Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis. Phytomedicine, 2021; 92:153739; doi: 10.1016/j.phymed.2021.153739
21.
HuangY, ZhuX, ChenK, et al.Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway. Aging (Albany NY), 2019; 11(8):2217–2240; doi: 10.18632/aging.101910
22.
HungYL, FangSH, WangSC, et al.Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response. Sci Rep, 2017; 7:46299; doi: 10.1038/srep46299
23.
IrrcherI, LjubicicV, HoodDA. Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells. Am J Physiol Cell Physiol, 2009; 296(1):C116–C123; doi: 10.1152/ajpcell.00267.2007
24.
JeonSM. Regulation and function of AMPK in physiology and diseases. Exp Mol Med, 2016; 48(7):e245; doi: 10.1038/emm.2016.81
25.
KoliakiC, DalamagaM, KakounisK, et al.Metabolically healthy obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the controversies in disease development and progression. Curr Obes Rep, 2025; 14(1):46; doi: 10.1007/s13679-025-00637-9
26.
LiC, HouD, HuangY, et al.Corylin alleviated sepsis-associated cardiac dysfunction via attenuating inflammation through downregulation of microRNA-214-5p. Toxicol Res (Camb), 2024; 13(3):tfae081; doi: 10.1093/toxres/tfae081
27.
LiN, LiuT, ZhuS, et al.Corylin from Psoralea fructus (Psoralea corylifolia L.) protects against UV-induced skin aging by activating Nrf2 defense mechanisms. Phytother Res, 2022; 36(8):3276–3294; doi: 10.1002/ptr.7501
28.
LingJ, HuaL, QinY, et al.Perfluorooctane sulfonate promotes hepatic lipid accumulation and steatosis in high-fat diet mice through AMP-activated protein kinase/acetyl-CoA carboxylase (AMPK/ACC) pathway. J Appl Toxicol, 2023; 43(2):312–322; doi: 10.1002/jat.4383
29.
LiuB, DengX, JiangQ, et al.Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages. Biomed Pharmacother, 2020; 125:109895; doi: 10.1016/j.biopha.2020.109895
30.
LiuXY, LiuRX, HouF, et al.Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro. Mol Med Rep, 2016; 14(4):3669–3675; doi: 10.3892/mmr.2016.5673
31.
LiuY, SunZ, DongR, et al.Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK/SREBP1 pathway. Phytomedicine, 2024a;126:155437; doi: 10.1016/j.phymed.2024.155437
32.
LiuY, ZhangY, YouG, et al.Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis. Inflamm Res, 2024b;73(1):47–63; doi: 10.1007/s00011-023-01819-8
33.
LvT, FanX, HeC, et al.SLC7A11-ROS/alphaKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression. Redox Biol, 2024; 72:103159; doi: 10.1016/j.redox.2024.103159
34.
Marcondes-de-CastroIA, Reis-BarbosaPH, MarinhoTS, et al.AMPK/mTOR pathway significance in healthy liver and non-alcoholic fatty liver disease and its progression. J Gastroenterol Hepatol, 2023; 38(11):1868–1876; doi: 10.1111/jgh.16272
35.
NogueiraJP, CusiK. Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: From bench to patient care. Diabetes Spectr, 2024; 37(1):20–28; doi: 10.2337/dsi23-0013
36.
SaaoudF, LiuL, XuK, et al.Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways. JCI Insight, 2023; 8(1):e158183; doi: 10.1172/jci.insight.158183
37.
SalminenA. AMPK signaling inhibits the differentiation of myofibroblasts: Impact on age-related tissue fibrosis and degeneration. Biogerontology, 2024; 25(1):83–106; doi: 10.1007/s10522-023-10072-9
38.
ShenB, WangY, ChengJ, et al.Pterostilbene alleviated NAFLD via AMPK/mTOR signaling pathways and autophagy by promoting Nrf2. Phytomedicine, 2023; 109:154561; doi: 10.1016/j.phymed.2022.154561
39.
SmithBK, MarcinkoK, DesjardinsEM, et al.Treatment of nonalcoholic fatty liver disease: Role of AMPK. Am J Physiol Endocrinol Metab, 2016; 311(4):E730–E740; doi: 10.1152/ajpendo.00225.2016
40.
TackeF, WeiskirchenR. Update on hepatic stellate cells: Pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol, 2012; 6(1):67–80; doi: 10.1586/egh.11.92
41.
TilgH, PettaS, StefanN, et al.Metabolic dysfunction-associated steatotic liver disease in adults: A review. JAMA, 2026; 335(2):163–174; doi: 10.1001/jama.2025.19615
42.
UtzschneiderKM, KahnSE. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab, 2006; 91(12):4753–4761; doi: 10.1210/jc.2006-0587
43.
WangQ, WeiS, ZhouS, et al.Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction. Immunol Cell Biol, 2020; 98(1):54–66; doi: 10.1111/imcb.12297
44.
WangTH, TsengWC, LeuYL, et al.The flavonoid corylin exhibits lifespan extension properties in mouse. Nat Commun, 2022; 13(1):1238; doi: 10.1038/s41467-022-28908-2
45.
XiuY, SuY, GaoL, et al.Corylin accelerated wound healing through SIRT1 and PI3K/AKT signaling: A candidate remedy for chronic non-healing wounds. Front Pharmacol, 2023; 14:1153810; doi: 10.3389/fphar.2023.1153810
46.
YangF, LiH, LiY, et al.Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis. Int Immunopharmacol, 2021; 99:108051; doi: 10.1016/j.intimp.2021.108051
47.
YiJ, WuS, TanS, et al.Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis. Cell Death Discov, 2021; 7(1):374; doi: 10.1038/s41420-021-00768-7
48.
YuAX, XuML, YaoP, et al.Corylin, a flavonoid derived from Psoralea Fructus, induces osteoblastic differentiation via estrogen and Wnt/beta-catenin signaling pathways. Faseb J, 2020; 34(3):4311–4328; doi: 10.1096/fj.201902319RRR
49.
YuM, ZhouM, LiJ, et al.Notch-activated mesenchymal stromal/stem cells enhance the protective effect against acetaminophen-induced acute liver injury by activating AMPK/SIRT1 pathway. Stem Cell Res Ther, 2022; 13(1):318; doi: 10.1186/s13287-022-02999-6
50.
ZhaoJ, LiuL, CaoYY, et al.MAFLD as part of systemic metabolic dysregulation. Hepatol Int, 2024; 18(Suppl 2):834–847; doi: 10.1007/s12072-024-10660-y
51.
ZhaoZ, LiuT, ZhuS, et al.Development and evaluation studies of Corylin loaded nanostructured lipid carriers gel for topical treatment of UV-induced skin aging. Exp Gerontol, 2021; 153:111499; doi: 10.1016/j.exger.2021.111499
52.
ZhengZG, ZhangX, LiuXX, et al.Inhibition of HSP90beta improves lipid disorders by promoting mature SREBPs degradation via the ubiquitin-proteasome system. Theranostics, 2019; 9(20):5769–5783; doi: 10.7150/thno.36505
53.
ZhuL, ZhangQ, HuaC, et al.Melatonin alleviates particulate matter-induced liver fibrosis by inhibiting ROS-mediated mitophagy and inflammation via Nrf2 activation. Ecotoxicol Environ Saf, 2023; 268:115717; doi: 10.1016/j.ecoenv.2023.115717
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
